Business
Results of Chinese hospital evaluations of myLotus
Results of Chinese hospital evaluations of myLotus.
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n \nRNS Number : 1139D Concepta PLC 29 January 2018 \n\n29 January 2018\nConcepta plc\n(\"Concepta\" or the \"Company\") \n \nResults of hospital evaluations of myLotus product in China \n \nConcepta plc, (AIM: CPT) the UK healthcare company and developer of a proprietary product targeted at the mobile health market with a primary focus on women's fertility, is pleased to announce the results of the hospital evaluations of its myLotus product in China, its launch market.\nOver a 12 week period (August - November 2017) the myLotus ovulation tests and pregnancy urine tests were compared to laboratory blood tests in 2 locations: Changhai Hospital (Shanghai) and SJZ Reproductive Hospital (Shijiazhuang).\n64 women participated in the LH** (ovulation) tests and 59 women in the hCG*** (pregnancy) tests.\nThe results of the hospital evaluations for ovulation testing showed 100% correlation between myLotus and laboratory blood tests. The evaluation also included a comparison with a leading home test. As myLotus also provides quantitative results, the evaluation showed that it is possible for women who commonly experience weaker positives to ascertain exactly when they are about to ovulate much more accurately in comparison to using the existing commercially available home tests.\nThe evaluations for pregnancy testing were equally impressive, with myLotus achieving a correlation of over 98% with blood tests.\nErik Henau, CEO of Concepta commented: \"The traditional route to market for fertility testing in China is via the hospital channel. We are currently building a network of distributors for whom these test results are invaluable when presenting myLotus to doctors. The sheer volume of patients is overloading the Chinese healthcare system and with many women classified as experiencing 'unexplained infertility' these results give doctors the confidence to recommend that couples should use myLotus to help them increase their chances of conceiving.\n\"In many other markets, the route to market differs to that of China in that a direct-to-consumer approach is common for products such as ours. However, as we look to expand and launch myLotus in these additional markets, gaining medical endorsement for the product will be crucial in building consumer trust in these early stages of our brand development, as well as directly re...